|
ILSbio Hosts U.S. Tour of Vietnamese Ministry of Health
Delegation:
 ILSbio
recently hosted a high level delegation from the Ministry of
Health of Vietnam for a series of meetings with key
officials in Washington, DC and for a health related tour of
the United States. The group wanted to learn how health
prevention, outreach and treatment programs are
 implemented
and managed at the national and local levels in the United
States. They were also interested in forming supporting
relationships with key U.S. officials, learning how Vietnam
could increase its role in collaborative research and the
growing international pharmaceutical testing and
manufacturing industry. Aspects of the meetings focused on
international women’s health programs.
 The
Washington DC area meetings included Regina Benjamin, M.D.,
United States Surgeon General; Frances E. Ashe-Goins, R.N.,
M.P.H., Deputy Director, Office on Women's Health, U.S.
Department of Health and Human Services; National
Institutes of Health officials; the Vice Director of the
National Cancer Institute (NCI); Dr. Douglas Lowy, Head
Signaling and Oncogenesis Section, NIH; the Director of the
Office of International Affairs of NCI; Martha Noland, JD
and Christine Carter, PhD,
MPH, Vice Presidents of the Society for Women’s Health
Research; Leland Spenser, M.D., MPH, Director Kent County
Department of Health, and other political and administrative
officials. The delegation also visited area biotech firms.
While at
ILSBio’s headquarters and laboratory in Chestertown
Maryland, the delegation members were the guests of honor at
a reception held by ILSbio and the Kent County Chamber of
Commerce. The attendance for the affair was excellent.
Local business people, community leaders and politicians met
the distinguished delegation from Vietnam and toured
ILSbio's newly renovated and expanded laboratories. It was
a great meet and greet event for all involved.
Following
the DC area meetings the delegation flew to Orlando to
attend the 102nd Annual American Association for Cancer
Research (AACR) meeting and convention, where ILSBio was
presenting. Of course, there were side trips to Disney
World and EPCOT Center.
After the
AACR the delegation flew to Seattle for meetings with
pharmaceutical and biotech companies, then on to San
Francisco. ILSBio’s long friend and associate, Eric Suba,
M.D., President of the Viet/American Cervical Cancer
Prevention Project that successfully implemented Pap
screening in Vietnam, hosted the delegation’s California
visit.
ILSBio’s
team led by Chief Executive Officer Richard Thorp, Client
Services Director Ed Dorr, Laboratory Services Manager
Bernard Kohl, Laboratory Services Fulfillment Supervisor
Jordan Brown and Administrative Officer Emily Genther
arranged the meetings and coordinated the delegation’s
visit. Xuan Van Le, M.D., Director of Research Pathology,
assisted as translator at various meetings.
ILSBio
has been actively collaborating with and assisting the
Vietnamese medical community for the past 15 years. During
that time, ILSBio has sponsored many fellowships at major
U.S. Universities for young Vietnamese doctors and has
conducted medical seminars and conferences in Vietnam.
-continued-
|
|
Visit the
Photo
Gallery for more pictures of the
delegation’s visit.
Contact ILSBio
for more information regarding clinical
trials and pharmaceutical manufacturing
opportunities in Vietnam and world-wide.
ILSbio Received a
Grant for the Production of
CCRS
(Comprehensive
Cancer Research Sets)
ILSBio recently
received an Economic Recovery
Therapeutic Research Grant to develop
Comprehensive Cancer Research Sets (CCRS).
This grant provided funding to purchase
equipment and complete prototypes needed
to produce CCRS.
The Comprehensive
Cancer Research Sets will permit
academic and small biotech researchers
to have access to the same type of
unified specimens that, until now,
could only be afforded by the largest
pharmaceutical organizations. “Our hope
is to expedite and facilitate cancer
discovery research by making access to
high quality, comprehensive, well
documented specimens available at an
affordable price,” says Richard Thorp,
ILSBio CEO.
Over the next two
years, CCRS sets will be produced for
each of the major cancer types. The
first CCRS set for Breast Cancer will
be complete by August 1. It will
contain 35 carefully documented breast
cancer cases that are representative of
the spectrum of types and stages. Each
case will be included in tissue and
protein microarrays.
Researchers will
be able to purchase aliquots of frozen
diseased and normal adjacent tissue,
DNA, RNA and m-RNA extracts, as well as
protein lysates and high throughput
dipsticks. The tissue and lysate arrays
may be purchased in small affordable
sets. Each CCRS will be carefully
maintained and documented. Whenever a
particular case becomes depleted, a
similar case will be substitutes and new
arrays will be produced.
In 2011, CCRS will
be produced for Colorectal, Lung, Brain,
Cervical, Ovarian and Prostate cancer.
Lymphoma , Leukemia , Sarcoma, Liver and
Skin Cancer CCRS are scheduled for
production in 2012. CCRS is a joint
venture between ILSBio, LLC and its
sister organization Protein
Biotechnologies, Inc. of Ramona CA.
Click here for more information on
CCRS
ILSbio
Selected to Participate:
ILSbio, LLC is proud to announce their
selection as a tissue supplier for "The
Cancer Genome Atlas". The Cancer Genome
Atlas (TCGA) is a comprehensive and
coordinated effort to accelerate our
understanding of the molecular basis of
cancer through the application of genome
analysis technologies, including
large-scale genome sequencing. TCGA is a
joint effort of the National Cancer
Institute (NCI) and the National Human
Genome Research Institute (NHGRI), which
are both part of the National Institutes
of Health, U.S. Department of Health and
Human Services.
Recent Articles of Interest
Quantitative assays for the measurement
of HER1-HER2 heterodimerization and
phosphorylation in cell lines and breast
tumors: applications for diagnostics and
targeted drug mechanism of action
Risk of breast cancer among daughters of
mothers with diabetes: a
population-based cohort study
Quote of the Month
"To raise
new questions, new possibilities, to
regard old problems from a new angle,
requires creative imagination and marks
real advance in science."
Albert Einstein
Send your
companies news and important industry
events to:
info@ilsbio.com
|
|
- Back to Home Page -
|
NEWS